0 followers
Y-mAbs is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer.
Thomas Gad
Halozyme Therapeutics
5 followers
REVOLUTION Medicines
5 followers
Kymera Therapeutics
5 followers
C4 Therapeutics
4 followers
Stemline Therapeutics
3 followers
Inari
3 followers
Prelude Therapeutics
3 followers
Active Motif
3 followers
Pivot Bio
2 followers
Vor Biopharma
2 followers
Generation Bio
2 followers
Explore companies